CopperLoaded Chitosan Nanoparticles

Chitosan, a naturally occurring polysaccharide derived from the deacetylation of chitin, has become a versatile carrier for nanotechnological applications. Its biocompatibility, biodegradability, and the presence of amino groups that can be easily modified make it especially attractive for delivering metal ions. When copper ions are incorporated into chitosan nanoparticles, the resulting hybrid material exhibits a unique combination of antimicrobial, anticancer, and catalytic properties.

Why Combine Copper with Chitosan?

Copper (Cu) is an essential trace element that participates in numerous enzymatic processes. In its ionic form (Cu²⁺), copper demonstrates strong oxidative activity, which can be exploited to destroy bacterial cells, generate reactive oxygen species (ROS), and interfere with tumor metabolism. However, free copper ions are toxic at high concentrations and can cause undesirable side effects. Embedding copper within a chitosan matrix addresses these challenges:

• Controlled Release: The polymer network slows ion diffusion, providing a sustained antibacterial or anticancer effect.
• Stability: Chitosan protects copper from premature oxidation and precipitation.
• Targeting: Surface functionalisation of chitosan enables attachment of ligands that direct nanoparticles to specific cells or tissues.

Synthesis Methods

Several straightforward techniques have been reported for preparing copperloaded chitosan nanoparticles (CuCSNPs). The most widely used are iongelation, coprecipitation, and spraydrying.

1. IonGelation (Polyelectrolyte Complexation)

In this method, a dilute solution of chitosan (0.52% w/v) is mixed with an aqueous copper salt (usually CuCl2HO) under stirring. Sodium tripolyphosphate (TPP) is then added dropwise as a crosslinker. The positively charged amino groups of chitosan interact with the negatively charged TPP, forming nanoscale beads that entrap copper ions.

2. Coprecipitation

Chitosan is dissolved in dilute acetic acid and the pH is adjusted to ~5.0. An aqueous solution of copper nitrate is added, followed by the slow addition of a base (e.g., NaOH) while maintaining vigorous stirring. Copper hydroxide precipitates within the polymeric network and is subsequently reduced to CuO or metallic Cu by mild heating (80120C) or by adding a reducing agent such as ascorbic acid.

3. SprayDrying

A feed solution containing chitosan, copper salt, and a suitable plasticiser (e.g., glycerol) is atomised through a nozzle into a hot chamber. Rapid solvent evaporation yields dry, spherical CuCSNPs with diameters ranging from 150nm to 600nm. This technique offers excellent scalability for industrial production.

Physicochemical Characteristics

Typical properties of CuCSNPs are summarised below:

• Size: 80350nm (dynamic light scattering)
• Zeta potential: +25 to +35mV (reflecting the protonated amine groups)
• Copper loading: 525% w/w, depending on the feed ratio
• Morphology: spherical to slightly irregular, as seen by transmission electron microscopy (TEM)
• Release profile: initial burst (1020% within first 2h) followed by a quasilinear release over 2472h at pH7.4.

Biological Activities

Antimicrobial Action

The synergistic effect of coppers oxidative stress and chitosans intrinsic membranedisrupting activity leads to potent broadspectrum activity against Grampositive (e.g., Staphylococcus aureus) and Gramnegative (e.g., Escherichia coli) bacteria, as well as fungi such as Candida albicans. Minimum inhibitory concentrations (MICs) are typically 28gmL of copper, a tenfold improvement over copper salts alone.

Anticancer Potential

In vitro studies on human breast (MDAMB231) and lung (A549) cancer cells have shown that CuCSNPs induce apoptosis via ROS generation, mitochondrial membrane depolarisation, and activation of caspase3. The nanoparticles exhibit a dosedependent IC of 37gmL copper, while normal fibroblasts remain largely unaffected at the same concentrations, highlighting selective toxicity.

Catalytic Uses

Embedded copper nanoparticles retain catalytic activity for reactions such as the Ullmann coupling and the reduction of 4nitrophenol. The chitosan shell prevents aggregation, allowing reuse of the catalyst for at least five cycles with <10% loss of activity.

Applications

• Wound dressings: Incorporating CuCSNPs into hydrogel or electrospun nanofibre mats creates antimicrobial patches that promote healing.
• Food packaging: Films containing CuCSNPs extend shelflife of perishable products by inhibiting microbial growth.
• Drug delivery carriers: Coloading of chemotherapeutic agents (e.g., doxorubicin) with copper provides a dual treatment modalitychemotherapy plus metalmediated ROS damage.
• Environmental remediation: CuCSNPs act as efficient adsorbents for heavy metals and as catalytic agents for degradation of organic pollutants in water.

Safety and Toxicology

While chitosan is recognised as safe (GRAS status), copper toxicity must be carefully managed. In vivo studies in rodents have shown that topical application of CuCSNP dressings does not cause systemic copper accumulation; blood copper levels remain within normal limits. Nevertheless, oral or intravenous administration requires rigorous dose optimisation and thorough pharmacokinetic profiling.

Future Perspectives

Research is moving toward multifunctional platforms where CuCSNPs are combined with other therapeutic agents (e.g., nitricoxide donors) or with targeting ligands such as folic acid or antibodies. Emerging smart systems exploit pHresponsive chitosan to trigger copper release in acidic tumor microenvironments. Scaling up production while maintaining uniform size distribution remains a challenge, but advances in microfluidic synthesis and continuous spraydrying are promising.

Key References

1. R. Kumar, S. Singh, Copperchitosan nanocomposites: synthesis, characterization, and antimicrobial activity, Int. J. Nanomedicine, 2022, 17, 12351249.
2. M. Liu etal., Dualmode anticancer therapy using copperloaded chitosan nanoparticles, J. Controlled Release, 2023, 357, 456466.
3. A. ElSharkawy, Iongelation preparation of CuCSNPs for wound healing, Materials Science & Engineering C, 2021, 123, 111840.
4. Y. Zhao, Catalytic performance of chitosanstabilised copper nanoparticles in organic synthesis, Catalysis Science & Technology, 2024, 14, 215227.
5. S. Patel, Safety assessment of copperchitosan nanomaterials in vivo, Toxicology Reports, 2023, 10, 645652.